Hyperhidrosis Treatments

This policy covers treatment of primary focal hyperhidrosis — including iontophoresis (e.g., Drionic), prescription topical aluminum chloride, botulinum toxin, and, only when strict medical necessity criteria are met, endoscopic thoracic sympathectomy (ETS) for palmar or palmar/axillary disease. Coverage is limited to persistent, severe focal hyperhidrosis after failure or intolerance of conservative therapy (typically ≥6 months), excludes generalized or cosmetic hyperhidrosis, requires absence of contraindications (pacemaker, arrhythmias, pregnancy, certain metal implants, epilepsy), treats ETS as a last‑resort invasive option with significant irreversible risks, and does not cover microwave therapy, liposuction-alone, or diathermy-alone for axillary sweat gland removal.

"Hyperhidrosis (defined as excessive sweating beyond that required to maintain normal body temperature)."